Caspase-9 (CASP9) is an initiator caspase that plays a central role in the intrinsic (mitochondrial) apoptosis pathway. Upon mitochondrial outer membrane permeabilization (MOMP), cytochrome c is released into the cytosol where it binds with Apaf-1 and dATP to form the apoptosome complex. This complex recruits and activates procaspase-9, initiating the caspase cascade that leads to apoptotic cell death. [@liang2021]
In neurodegenerative diseases, inappropriate activation of caspase-9 contributes to the progressive loss of neurons in Alzheimer's disease (AD), Parkinson's disease (PD), and other conditions. Caspase-9 deficiency has been shown to protect against AD pathology in mouse models, highlighting its pathogenic role. [@yuan2020]
| Attribute | Value |
|---|---|
| Protein Name | Caspase-9 |
| Gene | CASP9 |
| UniProt ID | P55210 |
| Molecular Weight | 47 kDa (proenzyme), 35 kDa (active) |
| Subcellular Localization | Mitochondria, Cytoplasm |
| Protein Family | Caspase family, cysteine proteases |
| Chromosome | 1p36.21 |
| Expression | Ubiquitous, high in brain |
Caspase-9 is synthesized as a zymogen (procaspase-9) consisting of 416 amino acids. The active enzyme is generated through proteolytic cleavage at specific aspartate residues. [@hamacher1994]
Prodomain (1-125): Contains the caspase recruitment domain (CARD) that mediates interaction with Apaf-1 in the apoptosome.
Large Subunit (125-317): Contains the catalytic cysteine residue (Cys287) and substrate-binding groove.
Small Subunit (317-416): Completes the active site and contributes to substrate specificity.
The apoptosome-mediated activation sequence: [@slee1999]
Caspase-9 preferentially cleaves after DEXD sequences, with key substrates including:
Caspase-9 plays a critical role in AD pathogenesis through multiple mechanisms: [@yuan2020][@ekert1999]
In PD, caspase-9 mediates dopaminergic neuron death through:
| Compound | Type | Development Status | Application |
|---|---|---|---|
| Z-LEHD-FMK | Peptide inhibitor | Research tool | Preclinical studies |
| Ac-DEVD-CHO | Peptide inhibitor | Research tool | In vitro studies |
| 3-Cl-AHPC | Small molecule | Preclinical | Anti-cancer, potential neuroprotection |
Mitochondrial Stress → MOMP → Cytochrome c Release
↓
Apoptosome Formation (Cytochrome c + Apaf-1 + dATP)
↓
Procaspase-9 Recruitment & Activation
↓
Caspase-9 Activation
↓
┌────────────────┼────────────────┐
↓ ↓ ↓
Caspase-3 Caspase-7 PARP cleavage
↓ ↓ ↓
Apoptosis Apoptosis DNA repair failure
| Protein | Interaction | Functional Consequence |
|---|---|---|
| Apaf-1 | CARD-CARD binding | Apoptosome formation |
| Cytochrome c | Cofactor binding | Apoptosome activation |
| XIAP | Direct inhibition | Caspase activity regulation |
| Smac/DIABLO | XIAP displacement | Caspase activation |